News Release

David Blohm takes on the Board of Director Chairman Role for Accelerated Cure Project for Multiple Sclerosis

(Waltham, MA March 16, 2010) - Accelerated Cure Project for Multiple Sclerosis, a national nonprofit organization, announced today that David Blohm has stepped up to take the position of Chairman on their Board of Directors, effective immediately. A member of the board for five years, Blohm has been instrumental in taking the organization to new levels.

David Blohm's career includes 32 years of entrepreneurship, mentoring and public service. As an active community member, Blohm also serves on the Board of True Engineering and he is the Vice-Chairman of the Ponds and Waterways Committee of the Town of Sudbury in Massachusetts. In the past, he has served as a Trustee of the Boston Children's Museum, President of Congregation B'nai Torah in Sudbury, a member of Massachusetts Governor Cellucci's Economic Development Council, an overseer of the Boston Science Museum, Chairman of the Massachusetts Software Council and a member of WGBH Corporate Executive Council. He continues to support synagogue activities, schools and various non-profit organizations. In addition, David Blohm is an award-winning nature photographer.

Carolyn Cronin, President and CEO of Accelerated Cure Project, said, "David's experience as a successful executive and entrepreneur continues to be a catalyst aimed at accelerating the pace and quality of scientific collaboration leading to a cure. Accelerated Cure Project is very grateful to have him as the chairman of the Board."

In Blohm's professional career, he co-founded MathSoft, Inc., a developer and marketer of mathematical calculation software used by students, teachers, scientists and engineers. Blohm and his co-founder brought the company from start-up to initial public offering (IPO) in 1993. In 1995, Blohm took the role of President and CEO of SmarterKids.com. He led the company to become an award-winning Internet retailer of children's educational products and services, and through its IPO in 1999 and subsequent merger in 2001.

"I was initially attracted to the Accelerated Cure Project because of the vision and quality of the founding team. In the last five years I have seen this vision develop into a totally new approach to solving the problems of MS as Accelerated Cure Project has become recognized worldwide for its leadership and quality. I am honored to have been considered for the position of Chariman," Blohm said about taking on the new position.

Blohm is a graduate of Boston College and lives in Sudbury, MA. He has four children and has been married to his wife Mary for 32 years. Mr. Blohm was diagnosed with Multiple Sclerosis in 2000.

About Accelerated Cure Project

Accelerated Cure Project is a national nonprofit organization whose mission is to accelerate the cure of multiple sclerosis (MS) by facilitating research that determines the causes and mechanisms of MS. Our primary strategic initiative is the establishment of the MS Repository, a large-scale collection of highly-characterized biosamples available to scientist at any organization who are conducting research that contributes to our mission. All data generated through analysis of MS Repository samples is contributed back to the Accelerated Cure Project, resulting in an increasingly valuable and comprehensive information resource that can be analyzed to reveal new insights about MS. For more information about the Accelerated Cure Project or to make a corporate or individual donation, call 781-487-0008, visit www.acceleratedcure.org, or send an email to info_no_spam_please_@i_mean_it.no_spam_whatsoever.acceleratedcure.org.

About Multiple Sclerosis

Multiple Sclerosis is a chronic demyelinating disorder of the central nervous system that often results in severe disability including the inability to walk, blindness, cognitive dysfunction, extreme fatigue and other serious symptoms. MS affects over 400,000 people in the US and 2 million individuals worldwide. The disorder occurs twice as often in women as in men. The cause is not known and there is no known cure.